EUVIMEDOpdag EUVIMED
Crossref

LINC02154 Promotes Esophageal Squamous Cell Carcinoma Progression via the PI3K–AKT–mTOR Signaling Pathway by Interacting With IGF2BP2

Mingyuan Zhang iD, Cai Zhang, Fuyou Zhou, Ruotong Yang, Yang Feng, Yangyang Ji, Huijun Ren, Liang Ming

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.23903 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2025. Written by Mingyuan Zhang and 7 co-authors. Institution: Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Major MEDLINE topics: TOR Serine-Threonine Kinases, RNA, Long Noncoding, Proto-Oncogene Proteins c-akt, Esophageal Squamous Cell Carcinoma. Cited 3 times so far (Crossref); 41 references. Funded by: This research was supported by the National Natural Science Foundation of China [grant numbers 82103324, 82172351, and 82472367] and the Natural Science Founda…, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

As important types of noncoding RNAs, long noncoding RNAs (lncRNAs) have been found to be involved in the progression of various cancers. Accumulating evidence indicates that LINC02154 plays a critical role in cancer progression, but the underlying mechanisms regulating esophageal squamous cell carcinoma (ESCC) remain unclear. Here, we found that LINC02154 is significantly upregulated in ESCC cell lines and ESCC tissues. LINC02154 knockdown significantly inhibited the proliferation and migration of ESCC cells in vitro and suppressed the progression of ESCC in vivo. Mechanistically, LINC02154 can bind to IGF2BP2 and activate the PI3K–AKT–mTOR signaling pathway. High expression of LINC02154 is positively correlated with poor prognosis in ESCC patients. In conclusion, LINC02154 functions as an oncogenic factor to facilitate ESCC progression through the IG2BP2–PI3K–AKT–mTOR pathway and has the potential to be a promising diagnostic marker and therapeutic target for ESCC patients.

Subjects

MeSH terms (MEDLINE)

TOR Serine-Threonine KinasesRNA, Long NoncodingProto-Oncogene Proteins c-aktEsophageal Squamous Cell CarcinomaEsophageal NeoplasmsPhosphatidylinositol 3-KinasesRNA-Binding ProteinsHumansSignal TransductionCell ProliferationAnimalsGene Expression Regulation, NeoplasticMiceDisease ProgressionCell MovementPrognosisCell Line, TumorFemaleMaleMice, NudeMiddle AgedBiomarkers, TumorMice, Inbred BALB C

Author keywords

IGF2BP2LINC02154esophageal squamous cell carcinoma

Substances

TOR Serine-Threonine KinasesRNA, Long NoncodingProto-Oncogene Proteins c-aktMTOR protein, humanPhosphatidylinositol 3-KinasesRNA-Binding ProteinsIGF2BP2 protein, humanBiomarkers, Tumor

Authors and institutions

  • Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Key Clinical Laboratory of Henan province, Zhengzhou, China.
  • Thoracic Department, Anyang Tumor Hospital, Henan Key Medical Laboratory of Precise Prevention and Treatment of Esophageal Cancer, Anyang, China.

ORCID profiles: Mingyuan Zhang

Funding

  • This research was supported by the National Natural Science Foundation of China [grant numbers 82103324, 82172351, and 82472367] and the Natural Science Founda…
  • National Natural Science Foundation of China

Cite

APA

Zhang, M., Zhang, C., Zhou, F., Yang, R., Feng, Y., Ji, Y., Ren, H., & Ming, L. (2025). LINC02154 Promotes Esophageal Squamous Cell Carcinoma Progression via the PI3K–AKT–mTOR Signaling Pathway by Interacting With IGF2BP2. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23903

Vancouver

Zhang M, Zhang C, Zhou F, Yang R, Feng Y, Ji Y, et al. LINC02154 Promotes Esophageal Squamous Cell Carcinoma Progression via the PI3K–AKT–mTOR Signaling Pathway by Interacting With IGF2BP2. Molecular Carcinogenesis. 2025. doi:10.1002/mc.23903

BibTeX
@article{Zhang2025,
  author = {Zhang, Mingyuan and Zhang, Cai and Zhou, Fuyou and Yang, Ruotong and Feng, Yang and Ji, Yangyang and Ren, Huijun and Ming, Liang},
  title = {LINC02154 Promotes Esophageal Squamous Cell Carcinoma Progression via the PI3K–AKT–mTOR Signaling Pathway by Interacting With IGF2BP2},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.23903}
}
Start for free →